Laura Sit

Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial

Ethan Basch, Allison M. Deal, Mark G. Kris et al. · Journal of Clinical Oncology · 2015 · 2.7K citations · Full text

Pharmacy, Health Informatics, Oncology +17

Development of the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

Ethan Basch, Bryce B. Reeve, Sandra A. Mitchell et al. · JNCI Journal of the National Cancer Institute · 2014 · 1.1K citations · Full text

Pharmacy, Oncology, Cancer Control +15

Adverse Symptom Event Reporting by Patients vs Clinicians: Relationships With Clinical Outcomes

Ethan Basch, Xiaoyu Jia, Glenn Heller et al. · JNCI Journal of the National Cancer Institute · 2009 · 627 citations

Pharmacy, Oncology, Clinical Epidemiology +16

Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial

Lajos Pusztai, Christina Yau, Denise M. Wolf et al. · Cancer Cell · 2021 · 330 citations · Full text

Medicine, Oncology, Pharmacology +10

Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies

Denise M. Wolf, Christina Yau, Julia Wulfkuhle et al. · Cancer Cell · 2022 · 326 citations · Full text

Medicine, Cancer Biology, Oncology +17